表紙:医療用酵素技術の世界市場:業界分析、市場規模、シェア、成長性、動向、予測:2020年~2030年
市場調査レポート
商品コード
953564

医療用酵素技術の世界市場:業界分析、市場規模、シェア、成長性、動向、予測:2020年~2030年

Medical Enzyme Technology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

出版日: | 発行: Transparency Market Research | ページ情報: 英文 223 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.18円
医療用酵素技術の世界市場:業界分析、市場規模、シェア、成長性、動向、予測:2020年~2030年
出版日: 2020年07月06日
発行: Transparency Market Research
ページ情報: 英文 223 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、世界の医療用酵素技術市場を調査したもので、市場の概要、酵素タイプ別、用途別、地域別の分析と予測、競合情勢、企業プロファイルなどの情報を提供しています。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

  • 定義
  • 市場指標
  • 市場力学
    • 成長促進要因
    • 成長阻害要因
    • 市場機会
  • 市場価値予測
  • 世界市場の展望

第5章 主な調査結果

  • 業界の主なイベント(合併、買収、提携、協力など)
  • 技術の進歩
  • 主な研究機関
  • 世界の主要国における疾患の有病率と発生率
  • COVID-19パンデミックの影響(バリューチェーンと短期/中期/長期的影響)

第6章 酵素タイプ別の市場分析と予測

  • イントロダクション
  • 市場シェア分析
  • 市場価値予測
    • 消化酵素
    • 血栓溶解酵素
    • 加水分解酵素
    • その他
  • 市場の魅力分析

第7章 用途別の市場分析と予測

  • イントロダクション
  • 市場シェア分析
  • 市場価値予測
    • 疾病治療
    • 診断ツール
    • 生物医学研究
    • その他
  • 市場の魅力分析

第8章 地域別の市場分析と予測

  • 地域市場の見通し
  • イントロダクション
  • 市場価値予測
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析

第9章 北米

  • 主な調査結果
  • 酵素タイプ別の市場価値予測:2018-2030
    • 消化酵素
    • 血栓溶解酵素
    • 加水分解酵素
    • その他
  • 用途別の市場価値予測:2018-2030
    • 病気の治療
    • 診断ツール
    • 生物医学研究
    • その他
  • 国別の市場価値予測:2018-2030
    • 米国
    • カナダ
  • 北米の医療用酵素技術市場の魅力分析
    • 酵素タイプ別
    • 用途別
    • 国別

第10章 欧州

第11章 アジア太平洋

第12章 ラテンアメリカ

第13章 中東・アフリカ

第14章 競合情勢

  • 各社の競合マトリックス(企業の階層と規模別)
  • 各社の市場シェア分析
  • 企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Genzyme Corporation (Sanofi)
    • Promega Corporation
    • Asahi Kasei Corporation
    • Takeda Pharmaceutical Company Limited
    • Cytiva (Danaher)
    • Agilent Technologies, Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Amano Enzyme Inc.
    • Novozymes A/S
図表

List of Tables

  • Table 01: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Enzyme Type, 2018-2030
  • Table 02: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Digestive Enzymes, 2018-2030
  • Table 03: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Thrombolytic Enzymes, 2018-2030
  • Table 04: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Hydrolases, 2018-2030
  • Table 05: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 06: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Disease Treatment, 2018-2030
  • Table 07: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Diagnostic Tools, 2018-2030
  • Table 08: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Region, 2018-2030
  • Table 09: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Country, 2018-2030
  • Table 10: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Enzyme Type, 2018-2030
  • Table 11: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Digestive Enzymes, 2018-2030
  • Table 12: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Thrombolytic Enzymes, 2018-2030
  • Table 13: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Hydrolases, 2018-2030
  • Table 14: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 15: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Disease Treatment, 2018-2030
  • Table 16: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Diagnostic Tools, 2018-2030
  • Table 17: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 18: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Enzyme Type, 2018-2030
  • Table 19: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Digestive Enzymes, 2018-2030
  • Table 20: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Thrombolytic Enzymes, 2018-2030
  • Table 21: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Hydrolases, 2018-2030
  • Table 22: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 23: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Disease Treatment, 2018-2030
  • Table 24: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Diagnostic Tools, 2018-2030
  • Table 25: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 26: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Enzyme Type, 2018-2030
  • Table 27: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Digestive Enzymes, 2018-2030
  • Table 28: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Thrombolytic Enzymes, 2018-2030
  • Table 29: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Hydrolases, 2018-2030
  • Table 30: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 31: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Disease Treatment, 2018-2030
  • Table 32: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Diagnostic Tools, 2018-2030
  • Table 33: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 34: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Enzyme Type, 2018-2030
  • Table 35: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Digestive Enzymes, 2018-2030
  • Table 36: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Thrombolytic Enzymes, 2018-2030
  • Table 37: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Hydrolases, 2018-2030
  • Table 38: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 39: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Disease Treatment, 2018-2030
  • Table 40: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Diagnostic Tools, 2018-2030
  • Table 41: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 42: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Enzyme Type, 2018-2030
  • Table 43: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Digestive Enzymes, 2018-2030
  • Table 44: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Thrombolytic Enzymes, 2018-2030
  • Table 45: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Hydrolases, 2018-2030
  • Table 46: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 47: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Disease Treatment, 2018-2030
  • Table 48: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Diagnostic Tools, 2018-2030

List of Figures

  • Figure 01: Global Medical Enzyme Technology Market
  • Figure 02: Global Medical Enzyme Technology Market Value (US$ Mn) by Region, 2019 and 2030
  • Figure 03: Global Medical Enzyme Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018-2030
  • Figure 04: Global Medical Enzyme Technology Market Value Share, by Enzyme Type, 2020
  • Figure 05: Global Medical Enzyme Technology Market Value Share, by Application, 2020
  • Figure 06: Global Medical Enzyme Technology market Value Share, by Region, 2020
  • Figure 08: Global Medical Enzyme Technology Market Attractiveness, by Enzyme Type, 2020-2030
  • Figure 07: Global Medical Enzyme Technology Market Value Share, by Enzyme Type, 2019 and 2030
  • Figure 09: Global Medical Enzyme Technology Market Value Share, by Digestive Enzymes, 2019 and 2030
  • Figure 10: Global Medical Enzyme Technology Market Attractiveness, by Digestive Enzymes, 2020-2030
  • Figure 11: Global Medical Enzyme Technology Market Value Share, by Thrombolytic Enzymes, 2019 and 2030
  • Figure 12: Global Medical Enzyme Technology Market Attractiveness, by Thrombolytic Enzymes, 2020-2030
  • Figure 13: Global Medical Enzyme Technology Market Value Share, by Hydrolases, 2019 and 2030
  • Figure 14: Global Medical Enzyme Technology Market Attractiveness, by Hydrolases, 2020-2030
  • Figure 15: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Digestive Enzymes, 2018-2030
  • Figure 16: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Thrombolytic Enzymes, 2018-2030
  • Figure 17: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hydrolases, 2018-2030
  • Figure 18: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2018-2030
  • Figure 19: Global Medical Enzyme Technology Market Value Share, by Application, 2019 and 2030
  • Figure 20: Global Medical Enzyme Technology Market Attractiveness, by Application, 2020-2030
  • Figure 21: Global Medical Enzyme Technology Market Value Share, by Disease Treatment, 2019 and 2030
  • Figure 22: Global Medical Enzyme Technology Market Attractiveness, by Disease Treatment, 2020-2030
  • Figure 23: Global Medical Enzyme Technology Market Value Share, by Diagnostic Tools, 2019 and 2030
  • Figure 24: Global Medical Enzyme Technology Market Attractiveness, by Diagnostic Tools, 2020-2030
  • Figure 25: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Disease Treatment, 2018-2030
  • Figure 26: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnostic Tools, 2018-2030
  • Figure 27: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biomedical Research, 2018-2030
  • Figure 28: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2018-2030
  • Figure 29: Medical Enzyme Technology Market: Regional Outlook
  • Figure 30: Global Medical Enzyme Technology Market Value (US$ Mn) and Y-o-Y Growth Rate (%) Forecast, 2018-2030
  • Figure 31: Global Medical Enzyme Technology Market Value Share, by Region, 2019 and 2030
  • Figure 32: Global Medical Enzyme Technology Market Attractiveness, by Region, 2020-2030
  • Figure 33: North America Medical Enzyme Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018-2030
  • Figure 34: Global Medical Enzyme Technology Market Value Share, by Country, 2019 and 2030
  • Figure 35: Global Medical Enzyme Technology Market Attractiveness, by Country, 2020-2030
  • Figure 36: Global Medical Enzyme Technology Market Value Share, by Enzyme Type, 2019 and 2030
  • Figure 37: Global Medical Enzyme Technology Market Attractiveness, by Enzyme Type, 2020-2030
  • Figure 38: Global Medical Enzyme Technology Market Value Share, by Application, 2019 and 2030
  • Figure 39: Global Medical Enzyme Technology Market Attractiveness, by Application, 2020-2030
  • Figure 40: Europe Medical Enzyme Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018-2030
  • Figure 41: Global Medical Enzyme Technology Market Value Share, by Country/Sub-region, 2019 and 2030
  • Figure 42: Global Medical Enzyme Technology Market Attractiveness, by Country/Sub-region, 2020-2030
  • Figure 43: Global Medical Enzyme Technology Market Value Share, by Enzyme Type, 2019 and 2030
  • Figure 44: Global Medical Enzyme Technology Market Attractiveness, by Enzyme Type, 2020-2030
  • Figure 45: Global Medical Enzyme Technology Market Value Share, by Application, 2019 and 2030
  • Figure 46: Global Medical Enzyme Technology Market Attractiveness, by Application, 2020-2030
  • Figure 47: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018-2030
  • Figure 48: Global Medical Enzyme Technology Market Value Share, by Country/Sub-region, 2019 and 2030
  • Figure 49: Global Medical Enzyme Technology Market Attractiveness, by Country/Sub-region, 2020-2030
  • Figure 50: Global Medical Enzyme Technology Market Value Share, by Enzyme Type, 2019 and 2030
  • Figure 51: Global Medical Enzyme Technology Market Attractiveness, by Enzyme Type, 2020-2030
  • Figure 52: Global Medical Enzyme Technology Market Value Share, by Application, 2019 and 2030
  • Figure 53: Global Medical Enzyme Technology Market Attractiveness, by Application, 2020-2030
  • Figure 54: Latin America Medical Enzyme Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018-2030
  • Figure 55: Latin America Medical Enzyme Technology Market Value Share, by Country/Sub-region, 2019 and 2030
  • Figure 56: Latin America Medical Enzyme Technology Market Attractiveness, by Country/Sub-region, 2020-2030
  • Figure 57: Latin America Medical Enzyme Technology Market Value Share, by Enzyme Type, 2019 and 2030
  • Figure 58: Latin America Medical Enzyme Technology Market Attractiveness, by Enzyme Type, 2020-2030
  • Figure 59: Latin America Medical Enzyme Technology Market Value Share, by Application, 2019 and 2030
  • Figure 60: Latin America Medical Enzyme Technology Market Attractiveness, by Application, 2020-2030
  • Figure 61: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018-2030
  • Figure 62: Middle East & Africa Medical Enzyme Technology Market Value Share, by Country/Sub-region, 2019 and 2030
  • Figure 63: Middle East & Africa Medical Enzyme Technology Market Attractiveness, by Country/Sub-region, 2020-2030
  • Figure 64: Middle East & Africa Medical Enzyme Technology Market Value Share, by Enzyme Type, 2019 and 2030
  • Figure 65: Middle East & Africa Medical Enzyme Technology Market Attractiveness, by Enzyme Type, 2020-2030
  • Figure 66: Middle East & Africa Medical Enzyme Technology Market Value Share, by Application, 2019 and 2030
  • Figure 67: Middle East & Africa Medical Enzyme Technology Market Attractiveness, by Application, 2020-2030
  • Figure 68: Global Medical Enzyme Technology Market Analysis, by Top Company Ranking, 2019
目次
Product Code: TMRGL1154

Title:
Medical Enzyme Technology Market (Enzyme Type: Digestive Enzymes, Thrombolytic Enzymes, Hyrolases, and Others; and Application: Disease Treatment, Diagnostic Tools, Biomedical Research, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030.

Scope of the Report

TMR's report on the global medical enzyme technology market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the global market during the forecast period from 2020 to 2030. The report provides the overall revenue of the global medical enzyme technology market from 2018 to 2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global medical enzyme technology market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with market leaders and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global medical enzyme technology market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global medical enzyme technology market.

The report includes an elaborate executive summary, along with a snapshot of the growth pattern of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competition dynamics in the global medical enzyme technology market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global medical enzyme technology market. The next section of the report highlights the USPs, which include key industry events (mergers, acquisitions, partnerships, collaborations, etc.), technological advancements, major research institutes involved, disease prevalence & incidence rate globally with key countries, and COVID-19 pandemic impact on the industry (value chain and short/mid/long term impact), in the global medical enzyme technology market.

The report delves into the competition landscape of the global medical enzyme technology market. Key players operating in the global medical enzyme technology market have been identified and each one of these has been profiled for its distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global medical enzyme technology market report.

Key Questions Answered:

  • What will be the sales revenue generated by medical enzyme technology across all regions during the forecast period?
  • What are the key trends in the global medical enzyme technology market?
  • What are major drivers, restraints, and opportunities in the global medical enzyme technology market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which application segment will generate the maximum revenue by 2030 and which service type segment will expand at the fastest CAGR during the forecast period?

Research Objectives and Research Approach

The comprehensive report on the global medical enzyme technology market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global medical enzyme technology market. It is followed by market introduction, market dynamics, and an overview of the global medical enzyme technology market, which includes TMR's analysis of market drivers, restraints, and trends affecting the market. Furthermore, Y-o-Y growth analysis with elaborate insights has been provided to understand the Y-o-Y growth trends of the global market. The next section of the global medical enzyme technology market report highlights the USPs, which include key industry events (mergers, acquisitions, partnerships, collaborations, etc.), technological advancements, major research institutes involved, disease prevalence & incidence rate globally with key countries, and COVID-19 pandemic impact on industry (value chain and short/mid/long term impact), in the global medical enzyme technology market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key players in the global medical enzyme technology market has been mapped to ascertain the size of the market in terms of value. The forecast presented here assesses the total revenue generated in the global medical enzyme technology market. In order to provide an accurate forecast, we initiated by sizing up the current medical enzyme technology market with the help of the parent market.

The report analyzes the global medical enzyme technology market in terms of enzyme type, application, and region. Key segments under each criteria have been studied at length and the market share of each of these by the end of 2030 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global medical enzyme technology market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Medical Enzyme Technology Market

4. Market Overview

  • 4.1. Definition
  • 4.2. Market Indicators
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, 2018-2030
  • 4.5. Global Medical Enzyme Technology Market Outlook

5. Key Insights

  • 5.1. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
  • 5.2. Technological Advancements
  • 5.3. Major Research Institutes Involved
  • 5.4. Disease Prevalence & Incidence Rate Globally in Key Countries
  • 5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)

6. Global Medical Enzyme Technology Market Analysis and Forecast, by Enzyme Type

  • 6.1. Introduction
  • 6.2. Global Medical Enzyme Technology Market Value Share Analysis, by Enzyme Type
  • 6.3. Global Medical Enzyme Technology Market Value Forecast, by Enzyme Type, 2018-2030
    • 6.3.1. Digestive Enzymes
      • 6.3.1.1. L-asparginase
      • 6.3.1.2. Lactase
      • 6.3.1.3. Others
    • 6.3.2. Thrombolytic Enzymes
      • 6.3.2.1. Streptokinase
      • 6.3.2.2. Urokinase
      • 6.3.2.3. Others
    • 6.3.3. Hydrolases
      • 6.3.3.1. Hyaluronidase
      • 6.3.3.2. Lysozyme
      • 6.3.3.3. Others
    • 6.3.4. Others
  • 6.4. Global Medical Enzyme Technology Market Attractiveness Analysis, by Enzyme Type

7. Global Medical Enzyme Technology Market Analysis and Forecast, by Application

  • 7.1. Introduction
  • 7.2. Global Medical Enzyme Technology Market Value Share Analysis, by Application
  • 7.3. Global Medical Enzyme Technology Market Value Forecast, by Application, 2018-2030
    • 7.3.1. Disease Treatment
      • 7.3.1.1. Cancer (Chemotherapy)
      • 7.3.1.2. Metabolic Diseases
      • 7.3.1.3. Others
    • 7.3.2. Diagnostic Tools
      • 7.3.2.1. Renal Disease
      • 7.3.2.2. Cancer
      • 7.3.2.3. Others
    • 7.3.3. Biomedical Research
    • 7.3.4. Others
  • 7.4. Global Medical Enzyme Technology Market Attractiveness Analysis, by Application

8. Global Medical Enzyme Technology Market Analysis and Forecast, by Region

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. Global Medical Enzyme Technology Market Value Forecast, by Region
    • 8.3.1. North America
    • 8.3.2. Europe
    • 8.3.3. Asia Pacific
    • 8.3.4. Latin America
    • 8.3.5. Middle East & Africa
  • 8.4. Global Medical Enzyme Technology Market Attractiveness Analysis, by Region

9. North America Medical Enzyme Technology Market Analysis and Forecast

  • 9.1. Key Findings
  • 9.2. North America Medical Enzyme Technology Market Value Forecast, by Enzyme Type, 2018-2030
    • 9.2.1. Digestive Enzymes
      • 9.2.1.1. L-asparginase
      • 9.2.1.2. Lactase
      • 9.2.1.3. Others
    • 9.2.2. Thrombolytic Enzymes
      • 9.2.2.1. Streptokinase
      • 9.2.2.2. Urokinase
      • 9.2.2.3. Others
    • 9.2.3. Hydrolases
      • 9.2.3.1. Hyaluronidase
      • 9.2.3.2. Lysozyme
      • 9.2.3.3. Others
    • 9.2.4. Others
  • 9.3. North America Medical Enzyme Technology Market Value Forecast, by Application, 2018-2030
    • 9.3.1. Disease Treatment
      • 9.3.1.1. Cancer (Chemotherapy)
      • 9.3.1.2. Metabolic Diseases
      • 9.3.1.3. Others
    • 9.3.2. Diagnostic Tools
      • 9.3.2.1. Renal Disease
      • 9.3.2.2. Cancer
      • 9.3.2.3. Others
    • 9.3.3. Biomedical Research
    • 9.3.4. Others
  • 9.4. North America Medical Enzyme Technology Market Value Forecast, by Country, 2018-2030
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. North America Medical Enzyme Technology Market Attractiveness Analysis
    • 9.5.1. By Enzyme Type
    • 9.5.2. By Application
    • 9.5.3. By Country

10. Europe Medical Enzyme Technology Market Analysis and Forecast

  • 10.1. Key Findings
  • 10.2. Europe Medical Enzyme Technology Market Value Forecast, by Enzyme Type, 2018-2030
    • 10.2.1. Digestive Enzymes
      • 10.2.1.1. L-asparginase
      • 10.2.1.2. Lactase
      • 10.2.1.3. Others
    • 10.2.2. Thrombolytic Enzymes
      • 10.2.2.1. Streptokinase
      • 10.2.2.2. Urokinase
      • 10.2.2.3. Others
    • 10.2.3. Hydrolases
      • 10.2.3.1. Hyaluronidase
      • 10.2.3.2. Lysozyme
      • 10.2.3.3. Others
    • 10.2.4. Others
  • 10.3. Europe Medical Enzyme Technology Market Value Forecast, by Application, 2018-2030
    • 10.3.1. Disease Treatment
      • 10.3.1.1. Cancer (Chemotherapy)
      • 10.3.1.2. Metabolic Diseases
      • 10.3.1.3. Others
    • 10.3.2. Diagnostic Tools
      • 10.3.2.1. Renal Disease
      • 10.3.2.2. Cancer
      • 10.3.2.3. Others
    • 10.3.3. Biomedical Research
    • 10.3.4. Others
  • 10.4. Europe Medical Enzyme Technology Market Value Forecast, by Country/Sub-region, 2018-2030
    • 10.4.1. U.K.
    • 10.4.2. Germany
    • 10.4.3. France
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Rest of Europe
  • 10.5. Europe Medical Enzyme Technology Market Attractiveness Analysis
    • 10.5.1. By Enzyme Type
    • 10.5.2. By Application
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Medical Enzyme Technology Market Analysis and Forecast

  • 11.1. Key Findings
  • 11.2. Asia Pacific Medical Enzyme Technology Market Value Forecast, By Enzyme Type, 2018-2030
    • 11.2.1. Digestive Enzymes
      • 11.2.1.1. L-asparginase
      • 11.2.1.2. Lactase
      • 11.2.1.3. Others
    • 11.2.2. Thrombolytic Enzymes
      • 11.2.2.1. Streptokinase
      • 11.2.2.2. Urokinase
      • 11.2.2.3. Others
    • 11.2.3. Hydrolases
      • 11.2.3.1. Hyaluronidase
      • 11.2.3.2. Lysozyme
      • 11.2.3.3. Others
    • 11.2.4. Others
  • 11.3. Asia Pacific Medical Enzyme Technology Market Value Forecast, by Application, 2018-2030
    • 11.3.1. Disease Treatment
      • 11.3.1.1. Cancer (Chemotherapy)
      • 11.3.1.2. Metabolic Diseases
      • 11.3.1.3. Others
    • 11.3.2. Diagnostic Tools
      • 11.3.2.1. Renal Disease
      • 11.3.2.2. Cancer
      • 11.3.2.3. Others
    • 11.3.3. Biomedical Research
    • 11.3.4. Others
  • 11.4. Asia Pacific Medical Enzyme Technology Market Value Forecast, by Country/Sub-region, 2018-2030
    • 11.4.1. China
    • 11.4.2. India
    • 11.4.3. Japan
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Asia Pacific Medical Enzyme Technology Market Attractiveness Analysis
    • 11.5.1. By Enzyme Type
    • 11.5.2. By Application
    • 11.5.3. By Country/Sub-region

12. Latin America Medical Enzyme Technology Market Analysis and Forecast

  • 12.1. Key Findings
  • 12.2. Latin America Medical Enzyme Technology Market Value Forecast, By Enzyme Type, 2018-2030
    • 12.2.1. Digestive Enzymes
      • 12.2.1.1. L-asparginase
      • 12.2.1.2. Lactase
      • 12.2.1.3. Others
    • 12.2.2. Thrombolytic Enzymes
      • 12.2.2.1. Streptokinase
      • 12.2.2.2. Urokinase
      • 12.2.2.3. Others
    • 12.2.3. Hydrolases
      • 12.2.3.1. Hyaluronidase
      • 12.2.3.2. Lysozyme
      • 12.2.3.3. Others
    • 12.2.4. Others
  • 12.3. Latin America Medical Enzyme Technology Market Value Forecast, by Application, 2018-2030
    • 12.3.1. Disease Treatment
      • 12.3.1.1. Cancer (Chemotherapy)
      • 12.3.1.2. Metabolic Diseases
      • 12.3.1.3. Others
    • 12.3.2. Diagnostic Tools
      • 12.3.2.1. Renal Disease
      • 12.3.2.2. Cancer
      • 12.3.2.3. Others
    • 12.3.3. Biomedical Research
    • 12.3.4. Others
  • 12.4. Latin America Medical Enzyme Technology Market Value Forecast, by Country/Sub-region, 2018-2030
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Latin America Medical Enzyme Technology Market Attractiveness Analysis
    • 12.5.1. By Enzyme Type
    • 12.5.2. By Application
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Medical Enzyme Technology Market Analysis and Forecast

  • 13.1. Key Findings
  • 13.2. Middle East & Africa Medical Enzyme Technology Market Value Forecast, By Enzyme Type, 2018-2030
    • 13.2.1. Digestive Enzymes
      • 13.2.1.1. L-asparginase
      • 13.2.1.2. Lactase
      • 13.2.1.3. Others
    • 13.2.2. Thrombolytic Enzymes
      • 13.2.2.1. Streptokinase
      • 13.2.2.2. Urokinase
      • 13.2.2.3. Others
    • 13.2.3. Hydrolases
      • 13.2.3.1. Hyaluronidase
      • 13.2.3.2. Lysozyme
      • 13.2.3.3. Others
    • 13.2.4. Others
  • 13.3. Middle East & Africa Medical Enzyme Technology Market Value Forecast, by Application, 2018-2030
    • 13.3.1. Disease Treatment
      • 13.3.1.1. Cancer (Chemotherapy)
      • 13.3.1.2. Metabolic Diseases
      • 13.3.1.3. Others
    • 13.3.2. Diagnostic Tools
      • 13.3.2.1. Renal Disease
      • 13.3.2.2. Cancer
      • 13.3.2.3. Others
    • 13.3.3. Biomedical Research
    • 13.3.4. Others
  • 13.4. Middle East & Africa Medical Enzyme Technology Market Value Forecast, by Country/Sub-region, 2018-2030
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Middle East & Africa Medical Enzyme Technology Market Attractiveness Analysis
    • 13.5.1. By Enzyme Type
    • 13.5.2. By Application
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by Tier and Size of Companies)
  • 14.2. Market Share Analysis, by Company, 2019
  • 14.3. Company Profiles
    • 14.3.1. Thermo Fisher Scientific Inc.
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Financial Overview
      • 14.3.1.3. Product Portfolio
      • 14.3.1.4. Strategic Overview
      • 14.3.1.5. SWOT Analysis
    • 14.3.2. Merck KGaA
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Financial Overview
      • 14.3.2.3. Product Portfolio
      • 14.3.2.4. Strategic Overview
      • 14.3.2.5. SWOT Analysis
    • 14.3.3. Genzyme Corporation (Sanofi)
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Financial Overview
      • 14.3.3.3. Product Portfolio
      • 14.3.3.4. Strategic Overview
      • 14.3.3.5. SWOT Analysis
    • 14.3.4. Promega Corporation
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Financial Overview
      • 14.3.4.3. Product Portfolio
      • 14.3.4.4. Strategic Overview
      • 14.3.4.5. SWOT Analysis
    • 14.3.5. Asahi Kasei Corporation
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Financial Overview
      • 14.3.5.3. Product Portfolio
      • 14.3.5.4. Strategic Overview
      • 14.3.5.5. SWOT Analysis
    • 14.3.6. Takeda Pharmaceutical Company Limited
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Financial Overview
      • 14.3.6.3. Product Portfolio
      • 14.3.6.4. Strategic Overview
      • 14.3.6.5. SWOT Analysis
    • 14.3.7. Cytiva (Danaher)
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Financial Overview
      • 14.3.7.3. Product Portfolio
      • 14.3.7.4. Strategic Overview
      • 14.3.7.5. SWOT Analysis
    • 14.3.8. Agilent Technologies, Inc.
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Financial Overview
      • 14.3.8.3. Product Portfolio
      • 14.3.8.4. Strategic Overview
      • 14.3.8.5. SWOT Analysis
    • 14.3.9. Sun Pharmaceutical Industries Ltd.
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Financial Overview
      • 14.3.9.3. Product Portfolio
      • 14.3.9.4. Strategic Overview
      • 14.3.9.5. SWOT Analysis
    • 14.3.10. Amano Enzyme Inc.
      • 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.10.2. Financial Overview
      • 14.3.10.3. Product Portfolio
      • 14.3.10.4. Strategic Overview
      • 14.3.10.5. SWOT Analysis
    • 14.3.11. Novozymes A/S
      • 14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.11.2. Financial Overview
      • 14.3.11.3. Product Portfolio
      • 14.3.11.4. Strategic Overview
      • 14.3.11.5. SWOT Analysis